Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2003
05/08/2003US20030087789 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract
05/08/2003US20030087307 Compound for use in the prevention and treatment of respiratory and nervous system disorders
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087264 Detection of regulatory response to pulsatile electromagnetic stimulus; obtain tissue sample, insert probe, apply pulsatile stimulus, detect gene expression, classify genes which are expresed
05/08/2003US20030087249 93870, a human G-protein coupled receptor and uses therefor
05/08/2003US20030086977 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated
05/08/2003US20030086971 For therapy of allergic and/or inflammatory conditions of the skin and airway passages
05/08/2003US20030086876 Pharmaceutical formulation of fluticasone propionate
05/08/2003CA2466824A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
05/08/2003CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003CA2464934A1 Pyrimido [4,5-b] indole derivatives
05/08/2003CA2464353A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003CA2464346A1 Water-soluble polymer conjugates of retinoic acid
05/08/2003CA2463770A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003CA2463580A1 Polymer conjugates of protein kinase c inhibitors
05/08/2003CA2463091A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003CA2462652A1 New bacterium causing poultry disease and vaccine derived thereof
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003CA2462206A1 Substituted thioacetamides
05/08/2003CA2426785A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/07/2003EP1308509A1 Novel physiologically active peptide and use thereof
05/07/2003EP1308446A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308441A1 2-aminopyridine compounds and use thereof as drugs
05/07/2003EP1308440A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient
05/07/2003EP1308438A1 3-substituted urea derivatives and medicinal use thereof
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307567A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
05/07/2003EP1307566A2 Mitogen activated kinase
05/07/2003EP1307559A2 Slit-like protein obtained from a cdna library from hs-5 stromal cell line
05/07/2003EP1307553A2 Mammalian dna binding membrane-associated protein-encoding gene and uses
05/07/2003EP1307540A2 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
05/07/2003EP1307461A2 Substituted pyrrole compounds and their use as spla2 inhibitors
05/07/2003EP1307458A1 Pyrrolotriazolopyrimidinone derivatives
05/07/2003EP1307457A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307453A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307441A1 1,3-dioxolanes with antitussive activity
05/07/2003EP1307440A1 2,2-disubstituted 1,3-dioxolanes as antitussive agents
05/07/2003EP1307432A1 Cyclic oxyguanidine protease inhibitors
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP1307208A1 Use of co for treating inflammation of upper airways or bronchi
05/07/2003EP1307190A1 Use of il-8 receptor antagonists in the treatment of virus infections
05/07/2003EP1307189A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
05/07/2003EP1307187A2 Use of 13-cis retinoic acid for the treatment of emphysema
05/07/2003EP1147110B1 Pyrazino(aza)indole derivatives
05/07/2003EP1131326B1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs
05/07/2003EP1124544B1 Dry powder pharmaceutical formulation
05/07/2003EP1112251B1 Azetidine derivatives, preparation and medicines containing them
05/07/2003EP1107775B1 Composition containing pyrrolizidine-alkaloid-free petasites
05/07/2003EP1095036B1 Cinnamic acid derivatives as cell adhesion molecules
05/07/2003EP1086079B1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids
05/07/2003EP1045822B1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
05/07/2003EP1019023B1 Stabilized preparations for use in nebulizers
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0831893B1 Regulation of neutrophil elastase synthesis and release
05/07/2003EP0749417B1 Cyano compounds and preparations thereof
05/07/2003CN1416421A New CCRS modulators: benzimidazoles or benzotriazoles
05/07/2003CN1416339A IL-8 receptor antagonsts
05/07/2003CN1415596A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science
05/07/2003CN1415377A Buccal tablets for nourishing yin to clear away the lung-heat
05/07/2003CN1415375A Ointment of Chinese traditional medicine for curing fever and cough
05/07/2003CN1415372A Medicament compsn. for curing acute pharyngitis and its preparation method
05/07/2003CN1415356A Medicament containing snail powder
05/07/2003CN1415354A Prepared Chinese medicine for curing pertinacious cough
05/07/2003CN1415335A Medical syrup for curing cough
05/07/2003CN1415324A Patent Chinese medicine for treating cough and gasp
05/07/2003CN1415319A Compsn. of Chinese traditional medicine for treating adenoids and its complicating disease
05/07/2003CN1415316A Medicament for treating quinsy
05/07/2003CN1415287A Hydrochloric ambroxol osmotic pump type controlled release formulation and its preparation method
05/07/2003CN1415286A Antibiotic antiinflammation preparation made from extract product of Yunnan loquat as essential component
05/07/2003CN1107680C Australian solanic amine salt hydrochloride its prodn. method and medical application
05/07/2003CN1107521C Method for reducing viscosity of pathological mucoid airway contents in respiratoy tract
05/07/2003CN1107513C Acupoint plaster agent for treating cough, asthma and diarrhea
05/06/2003USRE38115 Treating chronic or intractable pain, for treating tinnitus and for treating sexual dysfunction
05/06/2003US6559312 Intermediates useful for the preparation of antihistaminic piperidine derivatives
05/06/2003US6559293 Topiramate sodium trihydrate
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559159 Kappa opioid receptor ligands
05/06/2003CA2056068C Process
05/06/2003CA2032864C Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same
05/02/2003EP1306377A2 Pyridyl-oxazoles and their use as cytokines inhibitors
05/02/2003EP1306376A1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1306085A1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor
05/02/2003EP1305419A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305335A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
05/02/2003EP1305330A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
05/02/2003EP1305329A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
05/02/2003EP1305319A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/02/2003EP1305316A2 Azabicyclic derivatives and their therapeutic use
05/02/2003EP1305313A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors
1 ... 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 ... 878